Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07626216 · ClinicalTrials.gov registry record · Early Phase 1
Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia
A Early Phase 1 study, sponsored by Northwell Health.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT07626216 is a Early Phase 1 study that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 10 participants.
The verdict
NCT07626216, a Early Phase 1 study, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
By tracking resting-state fMRI scans, we aim to discover how repetitive transcranial magnetic stimulation (rTMS) changes brain connectivity in individuals with dystonia.
Interventions
- DEVICE Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-03-04 |
| Est. Completion | 2029-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07626216
The ClinicalTrials.gov registry entry for NCT07626216 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.
NCT07626216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07626216 about?
NCT07626216 is a clinical study titled "Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia". By tracking resting-state fMRI scans, we aim to discover how repetitive transcranial magnetic stimulation (rTMS) changes brain connectivity in individuals with dystonia.
What is the current status of trial NCT07626216?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2026-03-04. Estimated completion is 2029-05.
What interventions are being tested in trial NCT07626216?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT07626216?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.